Human chimeric antigen receptor macrophages for cancer immunotherapy-Reference-Cited by-同舟云学术

Human chimeric antigen receptor macrophages for cancer immunotherapy

Published:2020-03-23 Issue:8 Volume:38 Page:947-953
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Klichinsky Michael,Ruella Marco^ORCID,Shestova Olga,Lu Xueqing Maggie,Best Andrew,Zeeman Martha,Schmierer Maggie,Gabrusiewicz Konrad,Anderson Nicholas R.^ORCID,Petty Nicholas E.,Cummins Katherine D.,Shen Feng,Shan Xinhe^ORCID,Veliz Kimberly^ORCID,Blouch Kristin,Yashiro-Ohtani Yumi,Kenderian Saad S.,Kim Miriam Y.,O’Connor Roddy S.^ORCID,Wallace Stephen R.,Kozlowski Miroslaw S.,Marchione Dylan M.^ORCID,Shestov Maksim,Garcia Benjamin A.,June Carl H.,Gill Saar^ORCID

Funder

Penn | Perelman School of Medicine at the University of Pennsylvania | Abramson Family Cancer Research Institute

Carisma Therapeutics Inc. [Sponsored Research Agreement]

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/s41587-020-0462-y.pdf

Reference37 articles.

1. Maude, S. L. et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N. Engl. J. Med. 378, 439–448 (2018).

2. Schuster, S. J. et al. Chimeric antigen receptor T cells in refractory B-cell lymphomas. N. Engl. J. Med. 377, 2545–2554 (2017).